Pfizer jab safe for kids aged 5-11
Pfizer and BioNTech yesterday said trial results showed their coronavirus vaccine was safe and produced a robust immune response in children aged five to 11, adding that they would seek regulatory approval shortly. The vaccine would be administered at a lower dosage than for people over 12, they said.
"In participants five to 11 years of age, the vaccine was safe, well tolerated and showed robust neutralising antibody responses," US giant Pfizer and its German partner said.
They plan to submit their data to regulatory bodies in the European Union, the United States and around the world "as soon as possible".
Comments